|
000
| 00852nam##2200205za#4500 |
|---|
| 001 | 9.697642 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210624235554 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 150407|2009||||xxc|||||o f|0| 0 eng|d |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH14-99/2009E-PDF |
|---|
| 110 | 1 |aCanada. |bHealth Canada. |
|---|
| 245 | 10|aAudit of New Substances Assessment and Control Bureau : |h[electronic resource]|bfinal audit report / |c[by] Audit and Accountability Bureau. |
|---|
| 260 | |aOttawa - Ontario : |bHealth Canada |cSeptember 2009. |
|---|
| 300 | |a16p.|btable |
|---|
| 590 | |a13-10-Supp|b2013-04-13 |
|---|
| 775 | 08|tVérification du Bureau de l'évaluation et du contrôle des substances nouvelles : |w(CaOODSP)9.641677 |
|---|
| 856 | 40|ahttp://publications.gc.ca|qPDF|s68 KB|uhttps://publications.gc.ca/collections/collection_2013/sc-hc/H14-99-2009-eng.pdf |
|---|